Dr. Zaki Sherif is also a medical scientist in cancer research (breast and liver), translational medicine (biomarker discovery), and now in Long-COVID-19 (Post-Acute Sequalae of SARS-CoV-2). As a principal Investigator, his research works have been funded by leading biomedical research institutions such as the National Institutes of Health and American Cancer Society. He completed his graduate and medical school studies and trainings at University of Wisconsin, Howard, Georgetown, and Stanford Universities. Among his notable accomplishments are discovering novel genetic mutations in breast cancer and identifying potential biomarkers for early diagnosis of liver cancer. Dr. Zaki Sherif has numerous scientific publications and book chapters including one on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NAFLD/NASH). He sits on the editorial boards of six scientific journals and reviews over four dozen research papers annually for over fifteen journal publications. He has been recognized for his scientific accomplishments with national and international awards including the Hall of Fame Society for Science and Technology, American Association of Cancer Researchers, the American Association for the Advancement of Science, and the Society of Ethiopians Established in Diaspora among many others. Dr. Sherif has mentored and helped graduate scores of MDs and PhDs in the last two decades; served as a United Nations’ visiting scholar / Professor at Addis Ababa University Faculty of Medicine; submitted a blueprint proposal to the Ethiopian Government on cancer center design and operation and made trips to Ethiopia on medical missions and peace negotiations.